| Host: |
Goat |
| Applications: |
Pep-ELISA/WB |
| Reactivity: |
Human/Mouse/Rat/Cow |
| Note: |
STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Short Description: |
Goat polyclonal antibody anti-TSGA2 (Internal) is suitable for use in ELISA and Western Blot research applications. |
| Clonality: |
Polyclonal |
| Conjugation: |
Unconjugated |
| Isotype: |
IgG |
| Formulation: |
0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA |
| Purification: |
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide. |
| Concentration: |
0.5 mg/mL |
| Dilution Range: |
WB-0.1-0.3µg/mlELISA-antibody detection limit dilution 1:4000. |
| Storage Instruction: |
Store at-20°C on receipt and minimise freeze-thaw cycles. |
| Gene Symbol: |
RSPH1 |
| Gene ID: |
89765 |
| Uniprot ID: |
RSPH1_HUMAN |
| Immunogen Region: |
Internal |
| Accession Number: |
NP_543136.1 |
| Immunogen Sequence: |
HLNHRYQGKFLNKNP |
| Function | Functions as part of axonemal radial spoke complexes that play an important part in the motility of sperm and cilia. |
| Protein Name | Radial Spoke Head 1 HomologCancer/Testis Antigen 79Ct79Male Meiotic Metaphase Chromosome-Associated Acidic ProteinMeichroacidinTestis-Specific Gene A2 Protein |
| Cellular Localisation | CytoplasmChromosomeCytoskeletonCilium AxonemeFlagellum AxonemeCytoplasmic In Late SpermatocytesSecondary Spermatocytes And Round SpermatidsGathered Around Metaphase Chromosomes During Meiotic Divisions |
| Alternative Antibody Names | Anti-Radial Spoke Head 1 Homolog antibodyAnti-Cancer/Testis Antigen 79 antibodyAnti-Ct79 antibodyAnti-Male Meiotic Metaphase Chromosome-Associated Acidic Protein antibodyAnti-Meichroacidin antibodyAnti-Testis-Specific Gene A2 Protein antibodyAnti-RSPH1 antibodyAnti-TSA2 antibodyAnti-TSGA2 antibody |
Information sourced from Uniprot.org
12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance
